Search research articles
Contact Us
Filters
Showing results (131-140 of 209) with videos related to
Page
of 21
Sort By:
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
January 1, 1988
Carcinogenesis in rats by cyclic N-nitrosamines containing sulphur
W Lijinsky, R M Kovatch, L K Keefer, et al.
Organic Letters
|
December 4, 2009
Glycosylated PROLI/NO derivatives as nitric oxide prodrugs
Rahul S Nandurdikar, Anna E Maciag, Sam Y Hong, et al.
Leukemia Research
|
February 6, 2009
JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C)
Paul J Shami, Anna E Maciag, Jordan K Eddington, et al.
International Journal of Cancer
|
April 2, 2011
Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas
Evangelos Kogias, Nadja Osterberg, Brunhilde Baumer, et al.
Breast Cancer Research : BCR
|
May 14, 2008
TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells
Ann-Marie Simeone, Vanity McMurtry, René Nieves-Alicea, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 15, 2009
Synthesis and evaluation of piperazine and homopiperazine analogues of JS-K, an anti-cancer lead compound
Rahul S Nandurdikar, Anna E Maciag, Michael L Citro, et al.
Journal of Medicinal Chemistry
|
January 29, 2000
Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: in vitro antileukemic activity
J E Saavedra, P J Shami, L Y Wang, et al.
Organic Letters
|
September 4, 2010
"Click" reaction in conjunction with diazeniumdiolate chemistry: developing high-load nitric oxide donors
Oyebola A Oladeinde, Sam Y Hong, Ryan J Holland, et al.
Chemical Research in Toxicology
|
October 31, 2012
Cross-linking protein glutathionylation mediated by O2-arylated bis-diazeniumdiolate "Double JS-K"
Ryan J Holland, Anna E Maciag, Varun Kumar, et al.
Biochemical Pharmacology
|
August 28, 2010
JS-K, a nitric oxide-releasing prodrug, modulates ß-catenin/TCF signaling in leukemic Jurkat cells: evidence of an S-nitrosylated mechanism
Niharika Nath, Mitali Chattopadhyay, Liliya Pospishil, et al.
Page
of 21
Search research articles
Search
Showing results (131-140 of 209) with videos related to
Sort By:
Page
of 21
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
January 1, 1988
Carcinogenesis in rats by cyclic N-nitrosamines containing sulphur
W Lijinsky, R M Kovatch, L K Keefer, et al.
Organic Letters
|
December 4, 2009
Glycosylated PROLI/NO derivatives as nitric oxide prodrugs
Rahul S Nandurdikar, Anna E Maciag, Sam Y Hong, et al.
Leukemia Research
|
February 6, 2009
JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C)
Paul J Shami, Anna E Maciag, Jordan K Eddington, et al.
International Journal of Cancer
|
April 2, 2011
Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas
Evangelos Kogias, Nadja Osterberg, Brunhilde Baumer, et al.
Breast Cancer Research : BCR
|
May 14, 2008
TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells
Ann-Marie Simeone, Vanity McMurtry, René Nieves-Alicea, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 15, 2009
Synthesis and evaluation of piperazine and homopiperazine analogues of JS-K, an anti-cancer lead compound
Rahul S Nandurdikar, Anna E Maciag, Michael L Citro, et al.
Journal of Medicinal Chemistry
|
January 29, 2000
Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: in vitro antileukemic activity
J E Saavedra, P J Shami, L Y Wang, et al.
Organic Letters
|
September 4, 2010
"Click" reaction in conjunction with diazeniumdiolate chemistry: developing high-load nitric oxide donors
Oyebola A Oladeinde, Sam Y Hong, Ryan J Holland, et al.
Chemical Research in Toxicology
|
October 31, 2012
Cross-linking protein glutathionylation mediated by O2-arylated bis-diazeniumdiolate "Double JS-K"
Ryan J Holland, Anna E Maciag, Varun Kumar, et al.
Biochemical Pharmacology
|
August 28, 2010
JS-K, a nitric oxide-releasing prodrug, modulates ß-catenin/TCF signaling in leukemic Jurkat cells: evidence of an S-nitrosylated mechanism
Niharika Nath, Mitali Chattopadhyay, Liliya Pospishil, et al.
Page
of 21